Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for generics
CJEU rules that pay-for-delay agreements likely violate competition law where reverse payments occur without justifiable explanation CJEU rules that pay-for-delay agreements likely violate competition law where reverse payments occur without justifiable explanation Reviewed by Léon Dijkman on Thursday, January 30, 2020 Rating: 5
Does the doctrine of equivalents apply to novelty? Does the doctrine of equivalents apply to novelty? Reviewed by Eibhlin Vardy on Tuesday, October 31, 2017 Rating: 5
Biosimilars and generics as "rip-offs": when the facts may not matter Biosimilars and generics as "rip-offs": when the facts may not matter Reviewed by Neil Wilkof on Friday, March 10, 2017 Rating: 5
When litigants must be responsible -- and what happens when they're not: Lyrica pregabalin injunction is continued When litigants must be responsible -- and what happens when they're not: Lyrica pregabalin injunction is continued Reviewed by Jeremy on Monday, November 09, 2015 Rating: 5
Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part II) Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part II) Reviewed by Annsley Merelle Ward on Sunday, July 28, 2013 Rating: 5
Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part I) Generics behaving badly? BMS v Teva illustrates UK judicial mood towards generic launch plans (Part I) Reviewed by Annsley Merelle Ward on Sunday, July 28, 2013 Rating: 5
Novartis fails the priority test - more patents fall Novartis fails the priority test - more patents fall Reviewed by Darren Smyth on Tuesday, March 19, 2013 Rating: 5
French pharma packaging, IP and generics: can you help? French pharma packaging, IP and generics: can you help? Reviewed by Jeremy on Thursday, February 14, 2013 Rating: 5
EU pharma originators v generics: the latest news EU pharma originators v generics: the latest news Reviewed by Jeremy on Tuesday, January 12, 2010 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.